FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Lowlite Investments, Inc. D/B/A Olympia Pharmacy Trimix Recall

Trimix, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy · Orlando, FL

Risk level
Class II
Reported by FDA
Jul 17, 2013
Recall ID
D-787-2013
Check your lot numberHow we source this data

Summary

Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalled Trimix starting May 29, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-787-2013 on Jul 17, 2013. Reason: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Product description

Trimix, compounded by Olympia Pharmacy, Orlando, FL

Lot numbers, UPCs & expiration codes

B5015 Exp 8/15/13, C50001 Exp 8/28/13, B5011 Exp 8/1/13, C42215 Exp 6/22/13, A5028 Exp 6/2/13, B5011 Exp 6/1/13, B5020 Exp 6/1/13, B50112 Exp 8/11/13, C4186 Exp 6/18/13, C4158 Exp 6/15/13, C4149 Exp 6/14/13, C4111 Exp 6/11/13, B4124 Exp 8/12/13, B4154 Exp 8/15/13, B4198 Exp 8/19/13, B4226 Exp 8/22/13, B4268 Exp 8/22/13, C40522 Exp 9/5/13, C4118 Exp 9/1/13, C4711 Exp 9/7/13, C41121 Exp 9/11/13, C4126 Exp 9/12/13 and B42715 Exp 8/27/13.

Where it was sold

Nationwide and PR

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-787-2013
Classification
Class II
Status
Ongoing
Recall initiated
May 29, 2013
FDA report date
Jul 17, 2013
Quantity
24
Recall type
Voluntary: Firm initiated
Recalling firm
Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Original FDA data

Every field from FDA enforcement report D-787-2013, exactly as published.

Show all FDA fields
City
Orlando
State
FL
Status
Ongoing
Country
United States
Event ID
65360
Address
6700 Conroy Windermere Rd
Address (line 2)
Suite 140
Code information
B5015 Exp 8/15/13, C50001 Exp 8/28/13, B5011 Exp 8/1/13, C42215 Exp 6/22/13, A5028 Exp 6/2/13, B5011 Exp 6/1/13, B5020 Exp 6/1/13, B50112 Exp 8/11/13, C4186 Exp 6/18/13, C4158 Exp 6/15/13, C4149 Exp 6/14/13, C4111 Exp 6/11/13, B4124 Exp 8/12/13, B4154 Exp 8/15/13, B4198 Exp 8/19/13, B4226 Exp 8/22/13, B4268 Exp 8/22/13, C40522 Exp 9/5/13, C4118 Exp 9/1/13, C4711 Exp 9/7/13, C41121 Exp 9/11/13, C4126 Exp 9/12/13 and B42715 Exp 8/27/13.
Postal code
32835-3500
Report date
Jul 17, 2013
Product type
Drugs
Recall number
D-787-2013
Classification
Class II
Recalling firm
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Product quantity
24
Reason for recall
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Voluntary / mandated
Voluntary: Firm initiated
Product description
Trimix, compounded by Olympia Pharmacy, Orlando, FL
Distribution pattern
Nationwide and PR
Recall initiation date
May 29, 2013
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jul 11, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-787-2013, published Jul 17, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls